---
figid: PMC9695187__pharmaceuticals-15-01317-g003
pmcid: PMC9695187
image_filename: pharmaceuticals-15-01317-g003.jpg
figure_link: /pmc/articles/PMC9695187/figure/pharmaceuticals-15-01317-f003/
number: Figure 3
figure_title: ''
caption: 'In the ex vivo model, relative quantification of (a) IRS-1, (b) PI3K, (c)
  PKC-α (d) AKT2, and (e) GLUT4 expressions in diabetic, glimepiride, metformin, and
  palmatine treatment groups. The gene was normalized against a geometric mean of
  two housekeeping genes (β-actin and γ-actin). All the data points were presented
  as mean ± SD. Palmatine groups vs. other treatment groups: ** p < 0.01, *** p <
  0.001, **** p < 0.0001.'
article_title: Comparative Studies of Palmatine with Metformin and Glimepiride on
  the Modulation of Insulin Dependent Signaling Pathway In Vitro, In Vivo & Ex Vivo.
citation: Okechukwu Patrick Nwabueze, et al. Pharmaceuticals (Basel). 2022 Nov;15(11):1317.
year: '2022'

doi: 10.3390/ph15111317
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI

keywords:
- T2DM
- palmatine
- metformin
- glimepiride
- IRS1
- PI3K
- AKT2
- GLUT4

---
